Avid Bioservices Inc (CDMO)

[Protector]

RM, nobody said they needed to run the trials themselves. That ALSO are potentially revenue generating partnership possibilities for PPHM. That is what counts.

And the company said in so much words that they were done runing the late stage trials themselves. They have Cotara in an FDA design accepted Phase III, orphan status and fast track. If they can now position Cotara in a context as explained by Dr. Wolchok they re-inject potential value in the momentarily shelled program.

Question is and remains : Does PPHM even have someone that thinks about these possibilities even if it is just to evaluate their viability with a FULL view on things.

I proposed like a kind of handicapped story teller that doesn't see all the pieces but PPHM does see all the peaces.